Palmitic Acid-Conjugated Radiopharmaceutical for Integrin α<sub>v</sub>β<sub>3</sub>-Targeted Radionuclide Therapy
Peptide receptor radionuclide therapy (PRRT) is an emerging approach for patients with unresectable or metastatic tumors. Our previously optimized RGD peptide (3PRGD<sub>2</sub>) has excellent targeting specificity for a variety of integrin α<sub>v</sub>β<sub>3</sub&...
Saved in:
Main Authors: | Guangjie Yang (Author), Hannan Gao (Author), Chuangwei Luo (Author), Xiaoyu Zhao (Author), Qi Luo (Author), Jiyun Shi (Author), Fan Wang (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Radioimmune Imaging of α<sub>4</sub>β<sub>7</sub> Integrin and TNFα for Diagnostic and Therapeutic Applications in Inflammatory Bowel Disease
by: Alberto Signore, et al.
Published: (2023) -
Heterobivalent Dual-Target Peptide for Integrin-α<sub>v</sub>β<sub>3</sub> and Neuropeptide Y Receptors on Breast Tumor
by: Aryel H. Ferreira, et al.
Published: (2024) -
Aβ<sub>1-40</sub>-Induced Platelet Adhesion Is Ameliorated by Rosmarinic Acid through Inhibition of NADPH Oxidase/PKC-δ/Integrin α<sub>IIb</sub>β<sub>3</sub> Signaling
by: Bo Kyung Lee, et al.
Published: (2021) -
Absence of Oral Opportunistic Infections in Patients with Inflammatory Bowel Disease Receiving Anti-TNF-α and Anti-Integrin-α<sub>4</sub>β<sub>7</sub> Therapy
by: Ema Saltović, et al.
Published: (2022) -
Development and Evaluation of a Peptide Heterodimeric Tracer Targeting CXCR4 and Integrin α<sub>v</sub>β<sub>3</sub> for Pancreatic Cancer Imaging
by: Yaqun Jiang, et al.
Published: (2022)